Weaning Off Extended-Release Guanfacine
Guanfacine ER must be tapered by decreasing the dose by 1 mg every 3-7 days to avoid rebound hypertension—never discontinue abruptly. 1, 2
Tapering Protocol
The standard tapering schedule is to reduce the dose by 1 mg every 3-7 days until complete discontinuation. 1, 2 This gradual reduction is critical because guanfacine is an alpha-2A adrenergic receptor agonist that lowers blood pressure and heart rate, and sudden cessation can trigger rebound hypertension. 1
Specific Tapering Steps:
- If on 4 mg daily: Reduce to 3 mg for 3-7 days, then 2 mg for 3-7 days, then 1 mg for 3-7 days, then discontinue 1, 2
- If on 2 mg daily: Reduce to 1 mg for 3-7 days, then discontinue 1, 2
- If on 1 mg daily: Continue 1 mg for 3-7 days at a reduced frequency (e.g., every other day) before complete discontinuation, or taper more gradually if concerned about withdrawal 1
Timing of Rebound Effects
Rebound hypertension, when it occurs, typically manifests 2-4 days after abrupt discontinuation, which is delayed compared to clonidine due to guanfacine's longer half-life. 3 However, in most cases with proper tapering, blood pressure returns to pretreatment levels slowly (within 2-4 days) without adverse effects. 3
Monitoring During Taper
Monitor blood pressure and heart rate at each dose reduction, particularly in patients who experienced significant cardiovascular changes during treatment. 1, 2 Guanfacine typically decreases blood pressure by 1-4 mmHg and heart rate by 1-2 bpm, so expect gradual normalization during tapering. 1
Key Monitoring Parameters:
- Blood pressure and pulse at each dose step 1, 2
- ADHD symptom recurrence using parent and teacher reports 1
- Emergence of withdrawal symptoms (anxiety, agitation, headache) 1
Critical Safety Warnings
Patients who accidentally miss multiple doses should NOT restart at their previous full dose without medical guidance—contact the healthcare provider immediately. 1 Missing several doses effectively creates an unintentional abrupt discontinuation, increasing rebound risk.
The risk of rebound hypertension is relatively low with guanfacine compared to clonidine, but it remains a serious concern that mandates gradual tapering. 1, 3
Special Considerations
If the patient is on combination therapy with a stimulant: The stimulant can be continued at the current dose during guanfacine taper, as there are no contraindications to maintaining stimulant monotherapy. 1, 2
If switching to another ADHD medication: Initiate the new medication before completing the guanfacine taper to avoid a treatment gap, as guanfacine requires 2-4 weeks for therapeutic effects to dissipate. 1, 2
Counsel families about potential ADHD symptom recurrence: Since guanfacine provides "around-the-clock" symptom control, discontinuation will result in loss of coverage, and symptoms may return within days to weeks. 1